HIV infection, inflammation, immunosenescence, and aging - PubMed (original) (raw)

Review

HIV infection, inflammation, immunosenescence, and aging

Steven G Deeks. Annu Rev Med. 2011.

Abstract

Although antiretroviral therapy for HIV infection prevents AIDS-related complications and prolongs life, it does not fully restore health. Long-term treated patients remain at higher than expected risk for a number of complications typically associated with aging, including cardiovascular disease, cancer, osteoporosis, and other end-organ diseases. The potential effect of HIV on health is perhaps most clearly exhibited by a number of immunologic abnormalities that persist despite effective suppression of HIV replication. These changes are consistent with some of the changes to the adaptive immune system that are seen in the very old ("immunosenescence") and that are likely related in part to persistent inflammation. HIV-associated inflammation and immunosenescence have been implicated as causally related to the premature onset of other end-organ diseases. Novel therapeutic strategies aimed at preventing or reversing these immunologic defects may be necessary if HIV-infected patients are to achieve normal life span.

PubMed Disclaimer

Figures

Figure 1

Cited by

Screening NK-, B- and T-cell phenotype and function in patients suffering from Chronic Fatigue Syndrome.
Curriu M, Carrillo J, Massanella M, Rigau J, Alegre J, Puig J, Garcia-Quintana AM, Castro-Marrero J, Negredo E, Clotet B, Cabrera C, Blanco J. Curriu M, et al. J Transl Med. 2013 Mar 20;11:68. doi: 10.1186/1479-5876-11-68. J Transl Med. 2013. PMID: 23514202 Free PMC article.
Myocardial Infarction, Stroke, and Mortality in cART-Treated HIV Patients on Statins.
Krsak M, Kent DM, Terrin N, Holcroft C, Skinner SC, Wanke C. Krsak M, et al. AIDS Patient Care STDS. 2015 Jun;29(6):307-13. doi: 10.1089/apc.2014.0309. Epub 2015 Apr 9. AIDS Patient Care STDS. 2015. PMID: 25855882 Free PMC article.
Air Pollution Stress and the Aging Phenotype: The Telomere Connection.
Martens DS, Nawrot TS. Martens DS, et al. Curr Environ Health Rep. 2016 Sep;3(3):258-69. doi: 10.1007/s40572-016-0098-8. Curr Environ Health Rep. 2016. PMID: 27357566 Review.
Relationships of pulmonary function, inflammation, and T-cell activation and senescence in an HIV-infected cohort.
Fitzpatrick ME, Singh V, Bertolet M, Lucht L, Kessinger C, Michel J, Logar A, Weinman R, McMahon D, Norris KA, Vallejo AN, Morris A. Fitzpatrick ME, et al. AIDS. 2014 Nov 13;28(17):2505-15. doi: 10.1097/QAD.0000000000000471. AIDS. 2014. PMID: 25574956 Free PMC article.
Corneal endothelial cells provide evidence of accelerated cellular senescence associated with HIV infection: a case-control study.
Pathai S, Lawn SD, Shiels PG, Weiss HA, Cook C, Wood R, Gilbert CE. Pathai S, et al. PLoS One. 2013;8(2):e57422. doi: 10.1371/journal.pone.0057422. Epub 2013 Feb 27. PLoS One. 2013. PMID: 23460854 Free PMC article.

References

1. The Antiretroviral Therapy Cohort Collaboration. Life expectancy of individuals on combination antiretroviral therapy in high-income countries: a collaborative analysis of 14 cohort studies. Lancet. 2008;372:293–299. - PMC - PubMed
1. Bhaskaran K, Hamouda O, Sannes M, et al. Changes in the risk of death after HIV seroconversion compared with mortality in the general population. JAMA. 2008;300:51–59. - PubMed
1. Lohse N, Hansen AB, Pedersen G, et al. Survival of persons with and without HIV infection in Denmark,1995–2005. Ann. Intern. Med. 2007;146:87–95. - PubMed
1. Losina E, Schackman BR, Sadownik SN, et al. Racial and sex disparities in life expectancy losses among HIV-infected persons in the United States: impact of risk behavior, late initiation, and early discontinuation of antiretroviral therapy. Clin. Infect. Dis. 2009;49:1570–1578. - PMC - PubMed
1. Justice AC. HIV and aging: time for a new paradigm. Curr. HIV/AIDS Rep. 2010;7:69–76. - PubMed

HIV infection, inflammation, immunosenescence, and aging - PubMed (original) (raw)